Global High Potency API Market Survey and Trend Research 2018

June 2018 | 81 pages | ID: G6AAD69FDD7EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Pfizer, Novartis International, Sanofi, Boehringer Ingelheim, Teva Pharmaceutical, Teva Pharmaceutical, Eli Lilly and Company, GlaxoSmithKline, Merck & Co, AbbVie, Johnson & Johnson, Bayer, Mylan etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 High Potency API Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 HIGH POTENCY API MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Pfizer (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Novartis International (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Sanofi (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Boehringer Ingelheim (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Teva Pharmaceutical (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Teva Pharmaceutical (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Eli Lilly and Company (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 GlaxoSmithKline (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Merck & Co (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 AbbVie (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Johnson & Johnson (Company Overview, Sales Data etc.)
4.12 Bayer (Company Overview, Sales Data etc.)
4.13 Mylan (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

TABLE GLOBAL HIGH POTENCY API MARKET 2012-2017, BY TYPE, IN USD MILLION

Table Global High Potency API Market 2012-2017, by Type, in Volume
Table Global High Potency API Market Forecast 2018-2023, by Type, in USD Million
Table Global High Potency API Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table High Potency API Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis International Overview List
Table High Potency API Business Operation of Novartis International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table High Potency API Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table High Potency API Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table High Potency API Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table High Potency API Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table High Potency API Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table High Potency API Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co Overview List
Table High Potency API Business Operation of Merck & Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table High Potency API Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table High Potency API Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table High Potency API Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table High Potency API Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global High Potency API Sales Revenue 2012-2017, by Companies, in USD Million
Table Global High Potency API Sales Revenue Share, by Companies, in USD Million
Table Global High Potency API Sales Volume 2012-2017, by Companies, in Volume
Table Global High Potency API Sales Revenue Share, by Companies in 2017, in Volume
Table High Potency API Demand 2012-2017, by Application, in USD Million
Table High Potency API Demand 2012-2017, by Application, in Volume
Table High Potency API Demand Forecast 2018-2023, by Application, in USD Million
Table High Potency API Demand Forecast 2018-2023, by Application, in Volume
Table Global High Potency API Market 2012-2017, by Region, in USD Million
Table Global High Potency API Market 2012-2017, by Region, in Volume
Table High Potency API Market Forecast 2018-2023, by Region, in USD Million
Table High Potency API Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure High Potency API Industry Chain Structure
Figure Global High Potency API Market Growth 2012-2017, by Type, in USD Million
Figure Global High Potency API Market Growth 2012-2017, by Type, in Volume
Figure Global High Potency API Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global High Potency API Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region